New HPV vaccine may protect against 90% of cervical cancers
Conclusion
This double-blind randomised trial has shown that the new HPV vaccine provides increased protection from additional strains of HPV that cause cervical, vulval and vaginal cancers.
Strengths of the study include:
Blinding of the pathologists to the vaccine type, and blinding of the participants (they didn't know which vaccine they had been given), which reduces any bias – a double-blind randomised controlled trial is considered the gold standard of how best to assess a treatment or intervention.
The large number of women included in the study, with diverse ethnic backgrounds, makes it likely that the...
Source: NHS News Feed - February 20, 2015 Category: Consumer Health News Tags: Cancer Medication Source Type: news
New HPV approved after international phase 2/3 trial involving Moffitt Cancer Center
(H. Lee Moffitt Cancer Center & Research Institute) A pivotal international phase 2/3 clinical trial involving Moffitt Cancer Center faculty demonstrated that vaccination with Gardasil 9 protects against nine HPV types, seven of which cause most cases of cervical, vulvar, and vaginal disease. The trial data indicate that if populations are vaccinated with Gardasil 9 approximately 90 percent of all cervical cancers worldwide can be prevented. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2015 Category: Global & Universal Source Type: news
New HPV vaccine stops 90% of cervical cancers
Gardasil 9 offers the potential to increase overall cervical cancer prevention from 70 to 90 per cent, nearly eliminating this cancer among vaccinated women, scientists at Queen Mary University, London, say. (Source: the Mail online | Health)
Source: the Mail online | Health - February 19, 2015 Category: Consumer Health News Source Type: news
ABQ firm to produce second-generation HPV vaccine
Agilvax, an Albuquerque-based company, announced it has signed an agreement with a division of the National Institutes of Health to speed up the clinical development of its new second-generation HPV vaccine.
The new vaccine under development will be a virus-like particle vaccine. This means that it does not contain the actual virus, but rather multiprotein structures that mimic the virus, which could potentially lead to safer and cheaper vaccines. Gardasil, an existing HPV vaccine, already uses… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 3, 2015 Category: Biotechnology Authors: Andy Beale Source Type: news
Seeking Justice Through Vaccines, These Famous Artists Are Standing Up For Change
Beloved portrait photographer Annie Leibovitz often captures celebrity subjects before her noted lens, having snapped cultural icons ranging from John Lennon and Yoko Ono to Kim Kardashian and Kanye West.
Her most recent photograph, however, depicts a different sort of notable figures, those linked to the development of several life-saving vaccines. The image is part of the vaccination awareness campaign "The Art of Saving a Life (ASAL)," which, funded by the Bill and Melinda Gates Foundation, commissioned creative works from artists, writers and musicians, exhibiting the many ways vaccines have positively impacted histo...
Source: Science - The Huffington Post - February 3, 2015 Category: Science Source Type: news
News in Brief: Week of Jan. 5-9
This roundup includes the following news briefs: FDA Approves Gardasil 9 for HPV Prevention, Tips From Former Smokers Campaign Sees Return on Investment, PCORI Recruiting Members for Advisory Panels, AAMC Offers Three Free Publications, and FDA Warns Against Using Wallcur IV Products. (Source: AAFP News)
Source: AAFP News - January 9, 2015 Category: Primary Care Source Type: news
January Cervical Cancer Month: Progress Is Promising
January is Cervical Cancer Month. So it is time to look at what has been accomplished recently in control of this disease.
Getting treatment for advanced cervical cancer is challenging. Patients often have pelvic pain, sometimes with blockage of intestines and the urinary tract. Regrettably many patients have fistulas (holes) develop where they leak urine or stool through the skin, vagina or bladder. These are cruel consequences of failed cancer control. About 13,000 women will develop cervical cancer every year, and tragically 4,000 will die of the illness.
In 2014, the FDA approved a new treatment for advanced cervical...
Source: Healthy Living - The Huffington Post - January 9, 2015 Category: Consumer Health News Source Type: news
Human papillomavirus vaccine not linked to higher risk of MS
A study carried out in Denmark and Sweden has found that the human papillomavirus (HPV) vaccine does not increase the risk of developing MS. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 8, 2015 Category: Neurology Source Type: news
Two Doses of HPV Vaccine May Be More Cost-Effective Than Three (FREE)
By Kelly Young
Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM
Two doses of the human papillomavirus vaccine are likely to be more cost-effective than three doses if the two doses provide … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 8, 2015 Category: Primary Care Source Type: news
Gardasil 9 Vaccine for Prevention of Cancers Caused by Human Papillomavirus (HPV)
Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) is indicated for the prevention of cancers caused by some types of human papillomavirus (HPV). (Source: Drug Development Technology)
Source: Drug Development Technology - January 7, 2015 Category: Pharmaceuticals Source Type: news
Gardasil Does Not Increase MS RiskGardasil Does Not Increase MS Risk
A large Scandinavian study showed that the human papillomavirus vaccination is not associated with the development of multiple sclerosis or other demyelinating diseases. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 6, 2015 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Gardasil HPV Vaccine Not Linked To Multiple Sclerosis Or Related Diseases
The human papillomavirus (HPV) vaccine Gardasil is not linked to an increased risk of multiple sclerosis or any other similar central nervous system conditions, found a study published in JAMA today. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 6, 2015 Category: Pharmaceuticals Authors: Tara Haelle Source Type: news
HPV vaccination and MS risk
Brief interview article about a Danish/Swedish study that found no link between human papillomavirus vaccine (HPV) and an increased risk of MS.
Medical Research
Vaccinations - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 5, 2015 Category: Neurology Source Type: news
FDA Approves Merck's HPV Vaccine, GARDASIL®9, to Prevent Cancers and Other Diseases Caused by Nine HPV types – Including Types that Cause About 90% of Cervical Cancer Cases
Dateline City:
KENILWORTH, N.J.
GARDASIL 9 includes the greatest number of HPV types in any available HPV vaccine
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
announced today that the U.S.
Language:
English
Contact:
MerckMedia:Pamela Eisele, 267-305-3558Deb Wambold, 215-652-2913orInvesto...
Source: Merck.com - Product News - December 11, 2014 Category: Drugs & Pharmacology Tags: Prescription Medicine News Vaccine News Corporate News Latest News Source Type: news
FDA Approves Merck's Improved HPV Vax
Merck & Co. has received FDA approval for Gardasil 9, a new vaccine that provides broader protection than Merck's previously approved Gardasil against HPV-related cancers. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 11, 2014 Category: Pharmaceuticals Source Type: news
